Claris Biotherapeutics
Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in HALF MOON BAY, CALIFORNIA. Filed SEC Form D on 20260807 for a $55.7M Regulation D offering.
Biotech
📍 HALF MOON BAY, CALIFORNIA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Claris Biotherapeutics going public?
No. Claris Biotherapeutics is private and has not filed to go public. There is no S-1 on file.
What is Claris Biotherapeutics' valuation in 2026?
No confirmed valuation is on record for Claris Biotherapeutics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Claris Biotherapeutics filed an S-1?
No public S-1 is on file for Claris Biotherapeutics.
How much has Claris Biotherapeutics raised?
Claris Biotherapeutics has raised $55.74M in total, most recently a Form D filing of $55.74M in 20260807.
Is Claris Biotherapeutics publicly traded — can you buy Claris Biotherapeutics stock?
No. Claris Biotherapeutics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Claris Biotherapeutics on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
HQ
HALF MOON BAY, CALIFORNIA
Growth
Filed SEC Form D on 20260807 for $55.7M Regulation D offering
Last Round
Form D filing — $55.74M (20260807)
Fundraising Status
Form D filing · $55.74M
privateTotal raised $55.74M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $55.74M | 20260807 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
4
3 active · 3 recruiting
Lead phase
Phase 2
most advanced registered study
Focus areas
Limbal Stem Cell Deficiency
Corneal Scar · Neurotrophic Keratitis
Latest trial start
2026-05-22
Talent Signal
No public careers page or job board could be found for Claris Biotherapeutics as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.